SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Micron Solutions Inc/DE – ‘10-Q’ for 9/30/19

On:  Thursday, 11/14/19, at 2:17pm ET   ·   For:  9/30/19   ·   Accession #:  819689-19-99   ·   File #:  1-09731

Previous ‘10-Q’:  ‘10-Q’ on 8/14/19 for 6/30/19   ·   Latest ‘10-Q’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

11/14/19  Micron Solutions Inc/DE           10-Q        9/30/19   49:3.4M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    440K 
 2: EX-10.1     Material Contract                                   HTML     51K 
 3: EX-10.2     Material Contract                                   HTML     43K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     29K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     20K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     22K 
41: R1          Document and Entity Information                     HTML     50K 
27: R2          Condensed Consolidated Balance Sheets               HTML    104K 
14: R3          Condensed Consolidated Balance Sheets               HTML     38K 
                (Parenthetical)                                                  
38: R4          Condensed Consolidated Statements of Operations     HTML     63K 
42: R5          Condensed Consolidated Statements of Changes in     HTML     65K 
                Shareholders' Equity                                             
28: R6          Condensed Consolidated Statements of Cash Flows     HTML    104K 
15: R7          Basis of Presentation and Accounting Policies       HTML     31K 
37: R8          Inventories                                         HTML     35K 
43: R9          Property, Plant and Equipment, net                  HTML     59K 
35: R10         Assets Held For Sale                                HTML     20K 
47: R11         Debt                                                HTML     58K 
24: R12         Income Taxes                                        HTML     19K 
19: R13         Commitments and Contingencies                       HTML     21K 
36: R14         Shareholders' Equity                                HTML     78K 
48: R15         Basis of Presentation and Accounting Policies       HTML     35K 
                (Policies)                                                       
25: R16         Inventories (Tables)                                HTML     35K 
20: R17         Property, Plant and Equipment, net (Tables)         HTML     56K 
34: R18         Debt (Tables)                                       HTML     51K 
49: R19         Shareholders' Equity (Tables)                       HTML     64K 
30: R20         Basis of Presentation and Accounting Policies       HTML     27K 
                (Narrative) (Details)                                            
17: R21         Inventories (Narrative) (Details)                   HTML     16K 
39: R22         Inventories (Schedule Of Inventories) (Details)     HTML     27K 
44: R23         Property, Plant and Equipment, net (Narrative)      HTML     18K 
                (Details)                                                        
31: R24         Property, Plant and Equipment, net (Property,       HTML     48K 
                Plant and Equipment, net) (Details)                              
18: R25         Assets Held For Sale (Narrative) (Details)          HTML     23K 
40: R26         Debt (Bank Debt Narrative) (Details)                HTML     24K 
45: R27         Debt (Other Debt Narrative) (Details)               HTML     48K 
32: R28         Debt (Summary of Debt) (Details)                    HTML     37K 
16: R29         Debt (Schedule Of Related Parties Private           HTML     23K 
                Offering) (Details)                                              
22: R30         Income Taxes (Narrative) (Details)                  HTML     32K 
26: R31         Commitments and Contingencies (Narrative)           HTML     17K 
                (Details)                                                        
46: R32         Shareholders' Equity (Narrative) (Details)          HTML     87K 
33: R33         Shareholders' Equity (Stock Option Transactions)    HTML     52K 
                (Details)                                                        
29: XML         IDEA XML File -- Filing Summary                      XML     79K 
23: EXCEL       IDEA Workbook of Financial Reports                  XLSX     39K 
 8: EX-101.INS  XBRL Instance -- micr-20190930                       XML    806K 
10: EX-101.CAL  XBRL Calculations -- micr-20190930_cal               XML    104K 
11: EX-101.DEF  XBRL Definitions -- micr-20190930_def                XML    173K 
12: EX-101.LAB  XBRL Labels -- micr-20190930_lab                     XML    685K 
13: EX-101.PRE  XBRL Presentations -- micr-20190930_pre              XML    426K 
 9: EX-101.SCH  XBRL Schema -- micr-20190930                         XSD     77K 
21: ZIP         XBRL Zipped Folder -- 0000819689-19-000099-xbrl      Zip     69K 


‘10-Q’   —   Quarterly Report
Document Table of Contents

Page (sequential)   (alphabetic) Top
 
11st Page  –  Filing Submission
"Table of Contents
"Part I -- Condensed Financial Statements
"Item 1
"Condensed Consolidated Financial Statements
"Condensed Consolidated Balance Sheets
"Condensed Consolidated Statements of Operations
"C ondensed Consolidated Statements of Share holders' Equity
"Condensed Consolidated Statements of Cash Flows
"Notes to the Condensed Consolidated Financial Statements
"Item 2
"Management's Discussion and Analysis of Financial Condition and Results of Operations
"Item 3
"Quantitative and Qualitative Disclosures about Market Risk
"Item 4
"Controls and Procedures
"Part Ii -- Other Information
"Item 6
"Exhibit Index
"Signatures

This is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  10Q Q3 2019_Taxonomy2019  

Table of Contents

 











UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 10‑Q



 Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2019 or



Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ______ to ______

 

001-9731

(Commission file No.)



Micron Solutions, Inc.

(Exact name of registrant as specified in its charter)





 

 

DELAWARE

 

72‑0925679

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. employer identification no.)



25 Sawyer Passway

Fitchburg, Massachusetts  01420

(Address of principal executive offices and zip code)

 

(978) 345-5000

(Registrant's telephone number, including area code)



_________________________________________________________________

(Former name, former address and former fiscal year, if changed from last report)



Securities registered pursuant to Section 12(b) of the Act:





 

 

Title of each class

Trading symbol

Name of each exchange on which registered

Common Stock, $0.01 par value

MICR

New York Stock Exchange

  

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes    No 



Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes    No 



Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:





 

 

 

Large Accelerated filer  

Accelerated filer  

Non‑Accelerated filer  

Smaller reporting company  

Emerging growth company  



If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 



Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   Yes    No 

 

As of November 13, 2019 there were 2,895,362 shares of the Company’s common stock outstanding.








 

Table of Contents

 





Micron Solutions, Inc. and Subsidiary

TABLE OF CONTENTS





 

 

PART I - CONDENSED FINANCIAL STATEMENTS

Item 1

Condensed Consolidated Financial Statements



Condensed Consolidated Balance Sheets



Condensed Consolidated Statements of Operations



Condensed Consolidated Statements of Shareholders’ Equity



Condensed Consolidated Statements of Cash Flows



Notes to the Condensed Consolidated Financial Statements

Item 2

Management’s Discussion and Analysis of Financial Condition and Results of Operations

12 

Item 3

Quantitative and Qualitative Disclosures about Market Risk

16 

Item 4

Controls and Procedures

16 

PART II - OTHER INFORMATION

17 

Item 6

Exhibit Index

17 



SIGNATURES

18 

 



 


 

Table of Contents

 

PART I - CONDENSED FINANCIAL STATEMENTS

Item 1.  Condensed Consolidated Financial Statements (unaudited) 



Micron Solutions, Inc. and Subsidiary

Condensed Consolidated Balance Sheets

(unaudited)









 

 

 

 

 

 



 

 

 

 

 

 



 

September 30,

 

December 31,



 

2019

 

2018

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

503 

 

$

1,715 

Trade accounts receivable, net of allowance for doubtful accounts of $39,169 at September 30, 2019 and $40,000 at December 31, 2018

 

 

2,379,496 

 

 

2,325,804 

Inventories

 

 

2,639,385 

 

 

3,685,059 

Assets held for sale, net

 

 

 —

 

 

688,750 

Prepaid expenses and other current assets

 

 

279,215 

 

 

389,390 

Total current assets

 

 

5,298,599 

 

 

7,090,718 

Property, plant and equipment, net

 

 

4,148,730 

 

 

5,131,773 

Intangible assets, net

 

 

48,920 

 

 

53,155 

Other assets

 

 

5,145 

 

 

5,140 

Total assets

 

$

9,501,394 

 

$

12,280,786 

Liabilities and Shareholders’ Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Revolving line of credit

 

$

1,162,145 

 

$

2,025,592 

Term notes payable, current portion, net

 

 

389,420 

 

 

389,420 

Accounts payable

 

 

611,767 

 

 

1,200,298 

Accrued expenses and other current liabilities

 

 

785,449 

 

 

459,108 

Contract liabilities, current portion

 

 

24,723 

 

 

560,802 

Total current liabilities

 

 

2,973,504 

 

 

4,635,220 

Long-term liabilities:

 

 

 

 

 

 

Term notes payable, non-current portion, net

 

 

3,265,393 

 

 

3,557,458 

Subordinated promissory notes, net

 

 

467,167 

 

 

 —

Total long-term liabilities

 

 

3,732,560 

 

 

3,557,458 

Total liabilities

 

 

6,706,064 

 

 

8,192,678 

Commitments and Contingencies

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

Preferred stock, $0.001 par value; 2,000,000 shares authorized, none issued

 

 

 —

 

 

 —

Common stock, $0.01 par value; 10,000,000 shares authorized; 3,926,491 issued, 2,895,362 outstanding at September 30, 2019 and 3,926,491 issued, 2,861,008 outstanding at December 31, 2018

 

 

39,265 

 

 

39,265 

Additional paid-in-capital

 

 

11,715,002 

 

 

11,604,817 

Treasury stock at cost, 1,031,129 shares at September 30, 2019 and 1,065,483 shares at December 31, 2018

 

 

(2,813,745)

 

 

(2,907,490)

Accumulated deficit

 

 

(6,145,192)

 

 

(4,648,484)

Total shareholders’ equity

 

 

2,795,330 

 

 

4,088,108 

Total liabilities and shareholders’ equity

 

$

9,501,394 

 

$

12,280,786 



See accompanying notes to condensed consolidated financial statements.

 

3


 

Table of Contents

 

Micron Solutions, Inc. and Subsidiary

Condensed Consolidated Statements of Operations

(unaudited)







 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Nine Months Ended



 

September 30,

 

September 30,



 

2019

 

2018

 

2019

 

2018

Net sales

 

$

4,331,280 

 

$

5,001,660 

 

$

13,909,101 

 

$

15,441,134 

Cost of sales

 

 

3,813,882 

 

 

4,266,636 

 

 

12,227,430 

 

 

13,096,930 

Gross profit

 

 

517,398 

 

 

735,024 

 

 

1,681,671 

 

 

2,344,204 



 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing

 

 

170,065 

 

 

189,031 

 

 

486,449 

 

 

583,607 

General and administrative

 

 

700,622 

 

 

509,179 

 

 

2,283,563 

 

 

1,642,306 

Research and development

 

 

26,578 

 

 

25,372 

 

 

80,357 

 

 

80,094 

Total operating expenses

 

 

897,265 

 

 

723,582 

 

 

2,850,369 

 

 

2,306,007 



 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) from operations

 

 

(379,867)

 

 

11,442 

 

 

(1,168,698)

 

 

38,197 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(109,776)

 

 

(101,439)

 

 

(332,553)

 

 

(294,467)

Other income (expense), net

 

 

(17,334)

 

 

12,826 

 

 

4,543 

 

 

33,133 

Total other expense, net

 

 

(127,110)

 

 

(88,613)

 

 

(328,010)

 

 

(261,334)

Net income (loss) before income tax provision (benefit)

 

 

(506,977)

 

 

(77,171)

 

 

(1,496,708)

 

 

(223,137)

Income tax provision (benefit)

 

 

 —

 

 

 —

 

 

 —

 

 

 —

Net income (loss)

 

$

(506,977)

 

$

(77,171)

 

$

(1,496,708)

 

$

(223,137)

Earnings (loss) per share - basic

 

$

(0.18)

 

$

(0.03)

 

$

(0.52)

 

$

(0.08)

Earnings (loss) per share - diluted

 

$

(0.18)

 

$

(0.03)

 

$

(0.52)

 

$

(0.08)

Weighted average common shares outstanding - basic and diluted

 

 

2,889,408 

 

 

2,853,111 

 

 

2,878,049 

 

 

2,847,660 



 

 

 

 

 

 

 

 

 

 

 

 



See accompanying notes to condensed consolidated financial statements.



 

4


 

Table of Contents

 





Micron Solutions, Inc. and Subsidiary

Condensed Consolidated Statements of Shareholders’ Equity

(unaudited)







 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

 

 

 



 

Common stock

 

paid-in

 

 Treasury stock

 

 

Accumulated

 

 

 



 

Shares

 

Amount

 

capital

 

Shares

 

Amount

 

 

deficit

 

Total

December 31, 2017

 

3,926,491 

 

$

39,265 

 

$

11,532,207 

 

1,087,217 

 

$

(2,966,798)

 

 

$

(3,536,186)

 

$

5,068,488 

Change in Accounting Principle - ASC 606

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(13,991)

 

 

(13,991)

Share based compensation

 

 

 

 

 

 

 

14,370 

 

 

 

 

 

 

 

 

 

 

 

14,370 

Issuance of common stock
from treasury

 

 

 

 

 

 

 

4,427 

 

(5,661)

 

 

15,448 

 

 

 

 

 

 

19,875 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(179,647)

 

 

(179,647)

March 31, 2018

 

3,926,491 

 

$

39,265 

 

$

11,551,004 

 

1,081,556 

 

$

(2,951,350)

 

 

$

(3,729,824)

 

$

4,909,095 

Share-based compensation

 

 

 

 

 

 

 

8,817 

 

 

 

 

 

 

 

 

 

 

 

8,817 

Issuance of common stock
from treasury

 

 

 

 

 

 

 

5,571 

 

(5,242)

 

 

14,304 

 

 

 

 

 

 

19,875 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

33,681 

 

 

33,681 

June 30, 2018

 

3,926,491 

 

$

39,265 

 

$

11,565,392 

 

1,076,314 

 

$

(2,937,046)

 

 

$

(3,696,143)

 

$

4,971,468 

Share-based compensation

 

 

 

 

 

 

 

7,729 

 

 

 

 

 

 

 

 

 

 

 

7,729 

Issuance of common stock
from treasury

 

 

 

 

 

 

 

4,201 

 

(5,744)

 

 

15,674 

 

 

 

 

 

 

19,875 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(77,171)

 

 

(77,171)

September 30, 2018

 

3,926,491 

 

$

39,265 

 

$

11,577,322 

 

1,070,570 

 

$

(2,921,372)

 

 

$

(3,773,314)

 

$

4,921,901 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2018

 

3,926,491 

 

$

39,265 

 

$

11,604,817 

 

1,065,483 

 

$

(2,907,490)

 

 

$

(4,648,484)

 

$

4,088,108 

Share-based compensation

 

 

 

 

 

 

 

29,862 

 

 

 

 

 

 

 

 

 

 

 

29,862 

Issuance of common stock
from treasury

 

 

 

 

 

 

 

(2,562)

 

(11,200)

 

 

30,562 

 

 

 

 

 

 

28,000 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(518,773)

 

 

(518,773)

March 31, 2019

 

3,926,491 

 

$

39,265 

 

$

11,632,117 

 

1,054,283 

 

$

(2,876,928)

 

 

$

(5,167,257)

 

$

3,627,197 

Share-based compensation

 

 

 

 

 

 

 

30,000 

 

 

 

 

 

 

 

 

 

 

 

30,000 

Issuance of common stock
from treasury

 

 

 

 

 

 

 

(1,965)

 

(10,981)

 

 

29,965 

 

 

 

 

 

 

28,000 

Issuance of warrants

 

 

 

 

 

 

 

32,236 

 

 

 

 

 

 

 

 

 

 

 

32,236 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(470,958)

 

 

(470,958)

June 30, 2019

 

3,926,491 

 

$

39,265 

 

$

11,692,388 

 

1,043,302 

 

$

(2,846,963)

 

 

$

(5,638,215)

 

$

3,246,475 

Share-based compensation

 

 

 

 

 

 

 

24,250 

 

 

 

 

 

 

 

 

 

 

 

24,250 

Issuance of common stock
from treasury

 

 

 

 

 

 

 

(5,218)

 

(12,173)

 

 

33,218 

 

 

 

 

 

 

28,000 

Issuance of warrants

 

 

 

 

 

 

 

3,582 

 

 

 

 

 

 

 

 

 

 

 

3,582 

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(506,977)

 

 

(506,977)

September 30, 2019

 

3,926,491 

 

$

39,265 

 

$

11,715,002 

 

1,031,129 

 

$

(2,813,745)

 

 

$

(6,145,192)

 

$

2,795,330 



See accompanying notes to condensed consolidated financial statements.



5


 

Table of Contents

 



Micron Solutions, Inc. and Subsidiary

Condensed Consolidated Statements of Cash Flows

(unaudited)







 

 

 

 

 

 



 

 

 

 

 

 



 

Nine Months Ended



 

September 30,



 

2019

 

2018

Cash flows from operating activities:

 

 

 

 

 

 

Net loss

 

$

(1,496,708)

 

$

(223,137)

Adjustments to reconcile net loss to net cash provided by
operating activities:

 

 

 

 

 

 

Gain on sale of assets

 

 

(7,602)

 

 

 —

Depreciation and amortization

 

 

1,108,018 

 

 

1,130,000 

Non-cash interest expense

 

 

60,026 

 

 

50,443 

Change in allowance for doubtful accounts

 

 

831 

 

 

 —

Share-based compensation expense

 

 

168,112 

 

 

90,541 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(54,523)

 

 

(334,469)

Inventories

 

 

1,087,278 

 

 

(483,847)

Prepaid expenses and other current and non-current assets

 

 

110,170 

 

 

(98,922)

Other non-current assets

 

 

 —

 

 

1,000 

Accounts payable

 

 

(588,531)

 

 

(86,616)

Accrued expenses and other current liabilities

 

 

320,092 

 

 

297,228 

Contract liabilities

 

 

(536,079)

 

 

186,761 

Net cash provided by operating activities

 

 

171,084 

 

 

528,982 

Cash flows from investing activities:

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(161,928)

 

 

(456,488)

Proceeds from sale of property, plant and equipment

 

 

32,602 

 

 

 —

Proceeds from sale of assets held for sale

 

 

663,334 

 

 

 

Cash paid for patents and trademarks

 

 

 —

 

 

(2,661)

Net cash provided by (used in) investing activities

 

 

534,008 

 

 

(459,149)

Cash flows from financing activities:

 

 

 

 

 

 

Payments on revolving line of credit, net

 

 

(863,447)

 

 

(334,830)

Payments on term notes payable

 

 

(342,857)

 

 

(304,762)

Payments of debt issuance costs

 

 

 —

 

 

(34,389)

Proceeds from (payments on) subordinated debt

 

 

500,000 

 

 

(350,000)

Net cash provided by (used in) financing activities

 

 

(706,304)

 

 

(1,023,981)

Net change in cash and cash equivalents

 

 

(1,212)

 

 

(954,148)

Cash and cash equivalents, beginning of period

 

 

1,715 

 

 

956,988 

Cash and cash equivalents, end of period

 

$

503 

 

$

2,840 







 

 

 

 

 

 



 

 

 

 

 

 



 

 

 

 

 

 



 

Nine Months Ended



 

September 30,

Supplemental Cash Flow Information

 

2019

 

2018

Cash paid for interest

 

$

272,526 

 

$

244,819 



 

 

 

 

 

 

Non-cash activities:

 

 

 

 

 

 

Issuance of common stock warrants in connection with subordinated notes payable

 

$

35,818 

 

$

 —

Issuance of treasury stock for directors' fees

 

$

84,000 

 

$

45,426 

Adjustment to accumulated deficit for change in accounting principle (ASC 606)

 

$

 —

 

$

(13,991)



See accompanying notes to condensed consolidated financial statements.

 

 

1.  Basis of Presentation and Accounting Policies



The condensed consolidated financial statements (the "financial statements") include the accounts of Micron Solutions, Inc. (“Micron Solutions”) and its subsidiary, Micron Products, Inc. ("Micron" and together with Micron Solutions, the “Company”).  All intercompany balances and transactions have been eliminated in consolidation.



The financial statements and related notes have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC").  Accordingly, certain information and footnote disclosures normally included in complete financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been omitted pursuant to such rules and regulations.  These financial statements and related notes should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2018 filed with the SEC on March 19, 2019.



The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. The Company's balance sheet at December 31, 2018 has been derived from the audited financial statements at that date, but does not include all the information and footnotes required by GAAP for complete financial statements.



The information presented reflects, in the opinion of the management of the Company, all adjustments necessary for a fair presentation of the financial results for the interim periods presented. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. 



Liquidity and Management’s Plan



The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.



The Company identified certain conditions and events which in the aggregate required management to perform an assessment of the Company’s ability to continue as a going concern. These conditions included the Company’s negative financial history and the current liquidity position, including $503 of cash as of September 30, 2019 and approximately $1,000,000 of borrowing capacity on its revolving line of credit with Rockland Trust Company (the “Revolver”).    Management has performed an analysis to evaluate the entity’s ability to continue as a going concern for one year after the financial statements issuance date.



Management’s analysis includes forecasting future revenues, expenditures and cash flows, taking into consideration past performance and the requirements under the credit agreement.  Revenue and cash flow forecasts are dependent on the Company’s ability to fill booked orders from customers, its ability to close new and expanded business, its implementation of production efficiencies, and improvement of its overall financial performance.  In addition, the Company has amended its bank debt agreement to eliminate its debt service coverage covenant for the three months ended September 30, 2019.  





Based on management’s analysis, the Company believes that cash flows from its operations, together with its existing working capital, booked orders, expense management, and availability on its Revolver will be sufficient to fund operations at current levels and repay debt obligations over the next twelve months from the financial statements issuance date.  However, there can be no assurance that the Company will be able to do so.    



Recent Accounting Pronouncements



In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, “Leases,” which requires a lessee to recognize lease liabilities for the lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis, and right-of-use assets, representing the lessee’s right to use, or to control the use of, specified assets for the lease term.  The Company adopted the ASU on January 1, 2019 and, based on its current portfolio of leases (which consists solely of an office equipment lease), no lease assets or liabilities have been recognized in these financial statements,

Management does not expect any recently issued, but not yet effective, accounting standards to have a material effect on its results of operations or financial conditions. 



Revenue Recognition



During the nine months ended September 30, 2019, the Company recognized as revenue $546,889 of amounts recorded as Contract Liabilities at December 31, 2018.



2.  Inventories



Inventories consist of the following:







 

 

 

 

 

 



 

 

 

 

 

 



 

September 30,

 

December 31,



 

2019

 

2018

Raw materials

 

$

928,730 

 

$

1,079,887 

Work-in-process

 

 

407,775 

 

 

1,105,272 

Finished goods

 

 

1,302,880 

 

 

1,499,900 

Total

 

$

2,639,385 

 

$

3,685,059 



Silver included in raw materials, work-in-process and finished goods inventory had an estimated cost of $394,056 and $461,272 as of September 30, 2019 and December 31, 2018, respectively.

 

3.  Property, Plant and Equipment, net



Property, plant and equipment, net consist of the following:







 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 



 

Asset Lives

 

September 30,

 

December 31,



 

(in years)

 

2019

 

2018

Machinery and equipment

 

3

to

15

 

$

18,127,460 

 

$

17,978,781 

Building and improvements

 

5

to

25

 

 

3,991,951 

 

 

3,991,951 

Vehicles

 

3

to

5

 

 

100,096 

 

 

98,119 

Furniture, fixtures, computers and software

 

3

to

5

 

 

1,464,902 

 

 

1,440,071 

Construction in progress

 

 

 

 

 

 

25,208 

 

 

168,094 

Total property, plant and equipment

 

 

 

 

 

 

23,709,617 

 

 

23,677,016 

Less: accumulated depreciation

 

 

 

 

 

 

(19,560,887)

 

 

(18,545,243)

Property, plant and equipment, net

 

 

 

 

 

$

4,148,730 

 

$

5,131,773 



Construction in progress is generally comprised of internal tooling in process. 



For the three months ended September 30, 2019 and 2018, the Company recorded depreciation expense of $358,024 and $361,077, respectively. For the nine months ended September 30, 2019 and 2018, the Company recorded depreciation expense of $1,103,783 and $1,126,773, respectively.

 

4.  Assets Held for Sale



In January 2016, the Company entered into a Purchase and Sale Agreement with a buyer (collectively the “Parties”) to sell two unoccupied buildings, with a total of approximately 52,000 square feet, and land, at its Fitchburg, Massachusetts campus. As a result, the Company classified the property as Assets Held for Sale with a carrying value of $688,750,  which approximated the fair value less the expected cost to sell.



On August 6, 2019, the Company closed on the sale of the property and received proceeds of $663,334 which is net of selling costs incurred.







5.  Debt



The following table sets forth the items which comprise debt for the Company:









 

 

 

 

 

 



 

 

 

 

 

 



 

September 30,

 

December 31,



 

2019

 

2018

Revolving line of credit

 

$

1,162,145 

 

$

2,025,592 



 

 

 

 

 

 

Total term notes payable, net of issuance costs

 

$

3,654,813 

 

$

3,946,878 

Less current portion, net

 

 

389,420 

 

 

389,420 

Term notes payable, non-current, net

 

 

3,265,393 

 

 

3,557,458 



 

 

 

 

 

 

Subordinated notes payable, non-current, net

 

 

467,167 

 

 

 —

Total long term debt, net

 

 

3,732,560 

 

 

3,557,458 



 

 

 

 

 

 

Total short and long term debt, net

 

$

5,284,125 

 

$

5,972,470 





Availability to borrow under the Revolver is based on conditions defined in the credit agreement and amounts to $1,013,270, at September 30, 2019. The interest rate at September 30, 2019 was 5.36%.



The interest rate on the Term Notes at September 30, 2019 was 5.61%.    



Subordinated promissory notes



In June 2019, the Company initiated a private offering to raise up to $500,000 through the sale of subordinated promissory notes (the “Notes”).  The subscription for $500,000 was completed on July 5, 2019. The Notes bear interest on the unpaid principal at a simple annual interest rate equal to 10% per annum from the date of issuance. Interest only is payable in cash on a quarterly basis.  The Notes mature on June 28, 2022.  Each investor entered into a Subordination Agreement providing that the indebtedness pursuant to the Notes shall be subordinated to all indebtedness of the Company pursuant to its existing credit agreement with Rockland Trust Company



For every $50,000 in principal invested in the notes, each investor received a warrant to purchase 10,000 shares of common stock (collectively, the “Warrants”, see Note 8).  The Warrants are exercisable at an exercise price equal to $2.90 per share, namely, the average closing market price of the Company’s common stock on the fifteen days prior to the date of the Warrant, plus 12%. The Warrants contain standard provisions relating to anti-dilution adjustments for stock splits and recapitalizations.  The Warrants also provide the investors with standard piggy-back registration rights in the event the Company files a registration statement (other than a registration statement on Form S-4 or S-8) to register the shares of common stock subject to standard limitations in the discretion of any underwriter.



In order to account for the subordinated notes payable and warrants, the Company allocated the proceeds between the notes and warrants on a relative fair value basis.  As a result, the Company allocated $464,182 to the notes and $35,818 to the warrants.  The total discount on the notes is being recognized as non-cash interest expense over the term of the notes.  As of September 30, 2019, non-cash interest expense in the amount of $2,985 was recorded as amortization of the discount.



Related parties participated in the private offering as follows:



Jason Chambers, Director

$50,000

Rodd Friedman, Director

$100,000

Andrei Soran, Director

$50,000



 

6.  Income Taxes



As of September 30, 2019, the Company continues to maintain a valuation allowance against all of its domestic and foreign deferred tax assets, except for its AMT Credit carryforward, which is treated as a refundable attribute under the new tax law.



At September 30, 2019, the Company has federal and state net operating loss carryforwards totaling $11,300,000 and $12,195,000, respectively, which begin to expire in 2031. The Company also has federal and state tax credit carryovers of $306,000 and $278,000 respectively. The federal and state tax credits begin to expire in 2027 and 2019, respectively. 

 

7.  Commitments and Contingencies



Legal matters



In the ordinary course of its business, the Company is involved in various legal proceedings involving a variety of matters. The Company does not believe there are any pending legal proceedings that will have a material impact on the Company’s financial position or results of operations.



Off-balance sheet arrangements



Lease expense under all operating leases for the three months ended September 30, 2019 and 2018 was $4,713 and $6,056 respectively, and for the nine months ended September 30, 2019 and 2018, was $15,900 and $17,977 respectively.  The underlying lease is not being capitalized under ASC 842, Leases, as management has determined it is not material.

 

8.  Shareholders’ Equity



Stock options and share-based incentive plans



The following table sets forth the stock option transactions for the year ended September 30, 2019:







 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

Weighted

 

 

 



 

 

 

Weighted

 

average

 

 

 



 

 

 

Average

 

remaining

 

Aggregate



 

Number of

 

Exercise

 

contractual

 

Intrinsic



 

options

 

Price

 

term (in years)

 

Value

Outstanding at December 31, 2018

 

393,500 

 

$

4.89 

 

7.22 

 

$

960 

Granted

 

45,000 

 

 

2.50 

 

 

 

 

 

Forfeited

 

(48,337)

 

 

4.06 

 

 

 

 

 

Expired

 

(55,664)

 

 

5.68 

 

 

 

 

 

Outstanding at September 30, 2019

 

334,499 

 

$

4.56 

 

6.94 

 

$

 —

Exercisable at September 30, 2019

 

149,823 

 

$

6.02 

 

4.33 

 

$

 —

Exercisable at December 31, 2018

 

182,164 

 

$

6.09 

 

4.81 

 

$

960 



For the three months ended September 30, 2019 and 2018, share based compensation expense related to stock options amounted to $11,318 and $7,729, respectively.  For the nine months ended September 30, 2019 and 2018, those amounts were $56,662 and $30,910 respectively.  Share based compensation is included in general and administrative expenses.



For the three months ended September 30, 2019, 37,500 options were granted,  none were exercised and none were forfeited.    For the three months ended September 30, 2018, no options were granted, none were exercised and none were forfeited.    For the nine months ended September 30, 2018, 90,000 options were granted with a fair value of $0.50 per share, no options were exercised and 2,000 options were forfeited.



Unrecognized stock based compensation expense related to stock options as of September 30, 2019 was $108,571 which is expected to be recognized over a period of 2.7 years.



In March 2019, the Company issued 15,000 restricted stock units with a fair value of $3.20 per share which vest on the one year anniversary of the grant.    In September 2019, the Company issued 6,667 restricted stock units with a fair value of $2.25 per share and which vest one year from the date of grant.  For the three months ended September 30, 2019 and 2018, share based compensation expense related to restricted stock units amounted to $12,932 and $0, respectively. For the nine months ended September 30, 2019 and 2018, share based compensation expense related to restricted stock units amounted to $27,450 and $0, respectively.



 Unrecognized stock based compensation related to restricted stock units as of September 30, 2019 was $35,551,  which is expected to be recognized over a period of 0.65 years.



2019 Equity Incentive Plan

On March 25, 2019, the Company’s Board of Directors adopted the 2019 Equity Incentive Plan (the “2019 Plan”) which was approved by the stockholders at the May 23, 2019 Annual Meeting.  The 2019 Plan authorizes the issuance of an aggregate of 500,000 shares.  All non-issued shares of the 2010 Equity Incentive Plan expired upon the adoption of the 2019 Plan.  The 2019 Plan provides the Company flexibility to award a mix of stock options, equity incentive grants, performance awards and other types of stock-based compensation.



Warrants



On June 28, 2019, 90,000 warrants were issued with an exercise price of $2.90 in conjunction with the Company’s subordinated notes payable offering.  On July 5, 2019, 10,000 warrants were issued with an exercise price of $2.90.  The warrants are exercisable upon issuance for three years.  90,000 warrants expire in June 2022 and 10,000 warrants expire in July 2022.



Common Stock



For the three months ended September 30, 2019, the Company issued 12,173 shares of the Company’s common stock, with a fair value of $28,000 for director fees in lieu of cash payments.  For the three months ended September 30, 2018, the Company issued 5,744 shares of the Company’s common stock, with a fair value of $19,875 for director fees in lieu of cash payments.  For the nine months ended September 30, 2019, the Company issued 34,354 shares of the Company’s common stock, with a fair value of $84,000 for director fees in lieu of cash payments.  For the nine months ended September 30, 2018, the Company issued 16,647 shares of the Company’s common stock, with a fair value of $59,625 for director fees in lieu of cash payments.

















 

Item 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations



Forward-Looking Statements



This Quarterly Report on Form 10-Q contains forward-looking statements that involve a number of risks and uncertainties.

Any forward-looking statements made herein are based on current expectations of the Company that involve a number of risks and uncertainties and should not be considered as guarantees of future performance.  These statements are made under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements may be identified by the use of words such as “expect,” “anticipate,” “believe,” “intend,” “plans,” “predict,” or “will”. Although the Company believes that expectations are based on reasonable assumptions, management can give no assurance that the expectations will materialize.  Many factors could cause actual results to differ materially from the Company’s forward-looking statements.  These factors include the following, among other matters:  the Company's ability to obtain and retain order volumes from customers who represent high proportions of revenue; the Company's ability to maintain the pricing model, offset higher costs with price increases and/or decrease the cost of sales; the variability of customer delivery requirements and the ability of the Company to anticipate and respond thereto; the level of sales of higher margin products and services and the Company's ability to increase such sales; volatility in commodity and energy prices; the Company's level of debt and provisions in the debt agreements which could limit the Company's ability to react to changes in the economy or its industry; the Company's ability to comply with the financial and other covenants contained in its credit agreement, including as a result of events beyond its control, which could result in an event of default; the Company’s reliance on revenue from exports and the impact on the Company’s financial results due to economic uncertainty, changes in trade policy and tariffs, tax laws and regulations, or downturns in foreign markets; and continued availability of supplies or materials used in manufacturing at competitive prices.  The Company is under no obligation and does not intend to update, revise or otherwise publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of any unanticipated events. 



Overview



Micron Solutions, Inc., a Delaware corporation ("Micron Solutions”), through its wholly-owned Massachusetts subsidiary, Micron Products, Inc. (“Micron” and together with Micron Solutions, the "Company"), is a diversified contract manufacturing organization (“CMO”) that produces highly-engineered, innovative medical device components requiring precision machining and injection molding. The Company also manufactures components, devices and equipment for military, law enforcement, automotive and consumer product applications. The Company is engaged in the production and sale of silver/silver chloride coated and conductive resin sensors used as consumable component parts in the manufacture of integrated disposable electrophysiological sensors. These disposable medical devices are used worldwide in the monitoring of electrical signals in various medical applications. The Company's machining operations produce quick-turn, high volume patient-specific and off-the-shelf orthopedic implants and instruments.  The Company’s machining operations also include laser marking, automated polishing, passivation and coating. The Company has thermoplastic injection molding capabilities as well, and provides a full array of design, engineering, production services and management. The Company competes globally, with approximately forty-five percent of its revenue derived from exports.



Critical Accounting Policies



The critical accounting policies utilized by the Company in preparation of the accompanying financial statements are set forth in Part II, Item 7 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations”. There have been no material changes to these policies since December 31, 2018.



Liquidity and Management’s Plan



The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.



The Company identified certain conditions and events which in the aggregate required management to perform an assessment of the Company’s ability to continue as a going concern. These conditions included the Company’s negative financial history and the current liquidity position, including $503 of cash as of September 30, 2019 and approximately $1,000,000 of borrowing capacity on its revolving line of credit with Rockland Trust (the “Revolver”).  Management has performed an analysis to evaluate the entity’s ability to continue as a going concern for one year after the financial statements issuance date.



Management’s analysis includes forecasting future revenues, expenditures and cash flows, taking into consideration past performance and the requirements under the credit agreement.  Revenue and cash flow forecasts are dependent on the Company’s ability to fill booked orders from existing customers, its ability to close new and expanded business, its implementation of production efficiencies, and to improve overall financial performance.  In addition, the Company has amended its bank debt agreement to eliminate its debt service coverage covenant for the three months ended September 30, 2019.   



Based on management’s analysis, the Company believes that cash flows from its operations, together with its existing working capital, booked orders, expense management, and availability on its Revolver will be sufficient to fund operations at current levels and repay debt obligations over the next twelve months from the financial statements issuance date.  However, there can be no assurance that the Company will be able to do so.    

 





Results of Operations



The following table sets forth, for the periods indicated, the percentages of the net sales represented by certain items reflected in the Company's statements of operations.







 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Nine Months Ended



 

September 30,

 

September 30,



 

2019 

 

 

2018 

 

 

2019 

 

 

2018 

 

Net sales 

 

100.0 

%

 

100.0 

%

 

100.0 

%

 

100.0 

%

Cost of sales 

 

88.1 

 

 

85.3 

 

 

87.9 

 

 

84.8 

 

Gross profit 

 

11.9 

 

 

14.7 

 

 

12.1 

 

 

15.2 

 

Selling and marketing 

 

3.9 

 

 

3.8 

 

 

3.5 

 

 

3.8 

 

General and administrative 

 

16.2 

 

 

10.2 

 

 

16.4 

 

 

10.6 

 

Research and development 

 

0.6 

 

 

0.5 

 

 

0.6 

 

 

0.5 

 

Other expense

 

2.9 

 

 

1.8 

 

 

2.4 

 

 

1.7 

 

Loss before income tax provision (benefit)

 

(11.7)

 

 

(1.6)

 

 

(10.8)

 

 

(1.4)

 

Income tax provision (benefit)

 

 —

 

 

 —

 

 

 —

 

 

 —

 

Net income (loss)

 

(11.7)

%

 

(1.6)

%

 

(10.8)

%

 

(1.4)

%



Net Sales





 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

Net sales

 

2019

 

2018

 

$ Change

 

% Change

Three months ended September 30,

 

$

4,331,280 

 

$

5,001,660 

 

$

(670,380)

 

(13.4)%







 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

Net sales

 

2019

 

2018

 

$ Change

 

% Change

Nine months ended September 30,

 

$

13,909,101 

 

$

15,441,134 

 

$

(1,532,033)

 

(9.9)%



The decrease in consolidated net sales for the three months ended September 30, 2019 versus the prior year period was due primarily to a decrease in net sales of sensors, and lesser decreases for thermoplastic injection molding and tooling



The decrease in consolidated net sales for the nine months ended September 30, 2019 versus the prior year period was due primarily to a decrease in net sales of sensors and lesser decreases for machined components and thermoplastic injection molding, partially offset by increased tooling sales.



Gross Profit





 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

2019

 

2018

 

$ Change

 

% Change

Three months ended September 30,

 

$

517,398 

 

$

735,024 

 

$

(217,626)

 

(29.6)%

As a percentage of sales

 

 

11.9% 

 

 

14.7% 

 

 

 

 

 







 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

2019

 

2018

 

$ Change

 

% Change

Nine months ended September 30,

 

$

1,681,671 

 

$

2,344,204 

 

$

(662,533)

 

(28.3)%

As a percentage of sales

 

 

12.1% 

 

 

15.2% 

 

 

 

 

 



The decrease in consolidated gross profit for the three months ended September 30, 2019 versus the prior year period was due primarily to decreased  gross profits for sensors and lesser decreases for thermoplastic injection molding and tooling.



Gross profit expressed as a percentage of sales from sensors and thermoplastic injection molding decreased by 38% and 6.6%, respectively.  Gross profit as a percentage of sales from machined components increased by 68%.



The decrease in consolidated gross profit for the nine months ended September 30, 2019 versus the prior year period was due to decreased gross profits for sensors and for machined components.



Gross profit expressed as a percentage of sales from machined components decreased 48%.  Gross profit as a percentage of sales from sensors decreased by 29%.



Selling and Marketing



The Company's consolidated selling and marketing expenses amounted to $170,065  (3.9% of net sales) for the three months ended September 30, 2019 as compared to $189,031  (3.8% of net sales) for the three months ended September 30, 2018, a cost decrease of 10.0%.  For the three months ended September 30, 2019, the decrease was primarily due to lower marketing and consulting costs. Compensation was also lower due to the departure of a salesperson in the first quarter 2019.



The Company's consolidated selling and marketing expenses amounted to $486,450 (3.5% of net sales) for the nine months ended September 30, 2019 as compared to $583,606 (3.8% of net sales) for the nine months ended September 30, 2018, a decrease of 16.6%.  This decrease was primarily due to lower marketing and consulting costs. Compensation was also lower due to the departure of a salesperson in the first quarter 2019.



General and Administrative



The Company's consolidated general and administrative expenses was $700,622  (16.2% of net sales) for the three months ended September 30, 2019 as compared to $509,179  (10.2% of net sales) for the three months ended September 30, 2018, an increase of $191,443, or 37.6%



The increase in general and administrative expenses for the three months ended September 30, 2019 when compared to the same period in 2018 is due primarily to costs incurred associated with management and personnel restructuring and professional fees.



The Company's consolidated general and administrative expenses was $2,283,562 (16.4% of net sales) for the nine months ended September 30, 2019 as compared to $1,642,305 (10.6% of net sales) for the nine months ended September 30, 2018, an increase of $641,257, or 39%. 



The increase in general and administrative expenses for the nine months ended September 30, 2019 when compared to the same period in 2018 is due primarily to costs incurred associated with management and personnel restructuring, the recording of severance pay for the outgoing COO, consulting services, and professional fees.



Research and Development    



The Company's consolidated research and development expenses were level for the three months ended September 30, 2019 as compared to the three months ended September 30, 2018, at $26,578 and $25,372, respectively.



The Company's consolidated research and development expenses were level for the nine months ended September 30, 2019 as compared to the nine months ended September 30, 2018, at $80,357 and $80,094, respectively.



Other Expense, net



Other expense, net increased to $127,110 for the three months ended September 30, 2019, as compared to $88,613, for the three months ended September 30, 2018, an increase of $38,497.  The increase in other expense, net was due to an  $8,336 increase in interest expense,  $12,000 received in 2018 in extension fees related to the sale of the buildings, and other miscellaneous costs, net of a gain on the sale of fully depreciated fixed assets.



Other expense, net increased to $328,010 for the nine months ended September 30, 2019, as compared to $261,334, for the nine months ended September 30, 2018, an increase of $66,677.  The increase in other expense, net was due to a $38,085 increase in interest expense, $32,000 received in 2018 in extension fees related to the sale of the buildings, and other miscellaneous costs, net of a gain on the sale of fully depreciated fixed assets



Income Tax Provision



The tax provisions for the three months and nine months ended September 30, 2019 and 2018 attributable to the U.S. federal and state income taxes are $0. The Company’s combined federal and state effective income tax rate for the three months and nine months ended September 30, 2019 and 2018 of 0% is due to deferred tax assets being nearly fully reserved for with a valuation allowance.



Earnings (Loss) Per Share



Consolidated basic and diluted loss per share for the three months ended September 30, 2019 was $0.18 per share as compared to a loss per share of $0.03 for the same period in 2018, an increase in loss per share of $0.15. The increase in loss per share for the three months ended September 30, 2019, is due in part to decreased net sales of $670,380, decreased gross profit of $217,626 and an increase of $173,683 in operating expenses.

 

Consolidated basic and diluted loss per share for the nine months ended September 30, 2019 was $0.52 per share as compared to a loss per share of $0.08 for the same period in 2018, an increase in loss per share of $0.44.  The increase in loss per share for the nine months ended September 30, 2019, is due in part to decreased net sales of $1,532,033, decreased gross profit of $662,533 and an increase of $544,362 in operating expenses.



Off-Balance Sheet Arrangements



Lease expense under all operating leases for the three months ended September 30, 2019 and 2018 was $4,713 and $6,056,   respectively.  Lease expense for the nine months ended September 30, 2019 and 2018 was $15,900 and $17,977, respectively.

 

Liquidity and Capital Resources



Working capital was $2,325,095 as of September 30, 2019, as compared to $2,455,498 at December 31, 2018, a decrease of $130,403.  The decrease in working capital is due primarily to inventory reductions partially offset by decreases in the Revolver, accounts payable, and contract liabilities. 



Trade accounts receivable, net of allowance for doubtful accounts, were $2,379,496 and $2,325,804 at September 30, 2019 and December 31, 2018, respectively, an increase of $53,692



Inventories decreased by $1,045,674 from December 31, 2018 to $2,639,385 as of September 30, 2019 due to the reduction of tooling in process related to tooling sales and ongoing efforts to reduce inventory levels.



Accounts payable decreased from December 31, 2018 to September 30, 2019 by $588,531,  partially offset by a $320,092 increase in accrued expenses.    The increase in accrued expenses and other current liabilities was primarily due  to a severance arrangement with the former Chief Operating Officer of the Company, incentive compensation accruals, and increased accrued commissions for new programs including amounts for new outside sales representatives. Contract liabilities decreased by $536,079 due to the revenue recognition of several closed tooling projects.



Capital equipment expenditures of $161,928 for the nine months ended September 30, 2019 were primarily for robotic automation in custom molding.



At September 30, 2019 the Company’s total debt was $5,284,125 as compared to $5,972,470 at December 31, 2018, a decrease of $688,345.  The decrease in total debt is due to payments made on the Revolver and on Term Notes, offset by $500,000 in proceeds from the issuance of subordinated notes issued in July 2019.



Amounts available to borrow under the Revolver are $1,013,270 at September 30, 2019.



No dividends were declared or paid in the three and nine months ended September 30, 2019 and 2018.



The Company believes that cash flows from its operations, together with its existing working capital, booked orders, expense management, and its Revolver, will be sufficient to fund operations at current levels and repay debt obligations over the next twelve months from the date these financial statements were issued. However, there can be no assurance that the Company will be able to do so.



Summary of Changes in Cash Position



As of September 30, 2019, the Company had cash on hand of $503, as the Company’s cash is swept daily against the Revolver in accordance with the Company’s credit agreement.  For the nine months ended September 30, 2019,  cash provided by operating activities was $171,084.  Net cash provided by investing activities for the nine months ended September 30, 2019 was $534,008. Net cash used in financing activities for the nine months ended September 30, 2019 was $706,304. The net cash flows for the nine months ended September 30, 2019 are discussed in further detail below.



Operating Cash Flows 



For the nine months ended September 30, 2019, net cash provided by operating activities was $171,084,  primarily the result of the net loss, decreases in accounts payable and contract liabilities offset by cash provided from decreases in inventory and by increases in accrued expenses and other current liabilities as well as non-cash addbacks, primarily depreciation and amortization.



Investing Cash Flows



For the nine months ended September 30, 2019, net cash provided by investing activities was $534,008.  Proceeds from the sale of vacant buildings plus some fully depreciated equipment provided $695,936, offset by $161,928 in cash used for capital expenditures, primarily internal tooling and robotic automation for custom molding.



Financing Cash Flows



For the nine months ended September 30, 2019, net cash used by financing activities was $706,304 consisting of Revolver and term note repayments of $1,206,304, offset by $500,000 received from the issuance of subordinated notes payable.



 

Item 3.  Quantitative and Qualitative Disclosures about Market Risk



Not Applicable.



Item 4.  Controls and Procedures



Evaluation of Disclosure Controls and Procedures



Our principal executive officer and principal financial officer (“the Certifying Officers”) have evaluated the effectiveness of the Company's disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)).  Based on such evaluation, our Certifying Officers have concluded the Company's disclosure controls and procedures, as of the end of the period covered by this report, were effective.



The effectiveness of a system of disclosure controls and procedures is subject to various inherent limitations, including cost limitations, judgments used in decision making, assumptions about the likelihood of future events, the soundness of internal controls, and fraud. Due to such inherent limitations, there can be no assurance that any system of disclosure controls and procedures will be successful in preventing all errors or fraud, or in making all material information known in a timely manner to the appropriate levels of management.



Changes in Internal Control over Financial Reporting



During the three months ended September 30, 2019, there have been no changes in the Company's internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

6


 

Table of Contents

 

PART II - OTHER INFORMATION



Item 2. Unregistered Sales of Equity Securities and Use of Proceeds



On August 15, 2019, the Company granted, in the aggregate, 12,173 shares of Common Stock (the “Stock Grants”) pursuant to the Company’s 2019 Equity Incentive Plan to the members of the Board of Directors for the payment of their directors fees in the amount of approximately $28,000.  The Stock Grants were granted to the members of the Board of Directors, who are each “accredited investors” as such term is defined in the Securities Act of 1933, as amended (the “Securities Act”), pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.



Item 6. Exhibit Index





 

 

 

 

Exhibit
Number

 

Description of Exhibit

 

Page

4.1

 

Form of Subordinated Note (incorporated herein by reference to Exhibit 4.1 of the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 11, 2019.)

 

 

4.2

 

Form of Subordination Agreement (incorporated herein by reference to Exhibit 4.2 of the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 11, 2019).

 

 

4.3

 

Form of Warrant (incorporated herein by reference to Exhibit 4.3 of the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 11, 2019.)

 

 

10.1**

 

Second Amendment and Consent to Credit Agreement dated as of August 6, 2019 by and among Micron Products, Inc. (as Borrower), the Company (as Guarantor) and Rockland Trust Company.

 

X-1

10.2**

 

Third Amendment and Consent to Credit Agreement dated as of August 13, 2019 by and among Micron Products, Inc. (as Borrower), the Company (as Guarantor) and Rockland Trust Company.

 

X-2

10.3*

 

Employment Agreement dated July 15, 2019 between the Company and Wayne Coll (incorporated herein by reference to Exhibit 10.8 of the Company’s Current Report on form 8-K filed with the Securities and Exchange Commission on July 17, 2019.)

 

X-3

31.1**

 

Certification of the CEO pursuant to Rule 13a-14(a) or Rule 15(d)-14(a)

 

X-4

31.2**

 

Certification of the CFO pursuant to Rule 13a-14(a) or Rule 15(d)-14(a)

 

X-5



32.1**

 

Certification of the CEO pursuant to 18 U.S.C. §1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

X-6



32.2**

 

Certification of the CFO pursuant to 18 U.S.C. §1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

X-7

101.INS†

 

XBRL Instance Document

 

 

101.SCH†

 

XBRL Taxonomy Extension Schema Document

 

 

101.CAL†

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

101.PRE†

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

101.DEF†

 

XBRL Taxonomy Extension Definition Linkbase Document

 

 

*Indicates a management contract or compensatory plan required to be filed as an exhibit.

**Filed herewith

† XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

 

7


 

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.





MICRON SOLUTIONS, INC.

 



 

 



 

 

November 14, 2019

By:  /s/ William J. Laursen 

 



William J. Laursen

 



President and Chief Officer

 



(principal executive officer)

 

November 14, 2019

By:  /s/ Wayne Coll 

 



Wayne Coll

 



Chief Financial Officer

 



(principal financial and accounting officer)

 



 

 



 

 



 

8



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
12/31/1910-K
Filed on:11/14/19
11/13/198-K
For Period end:9/30/19S-8
8/15/194,  8-K
7/5/194
6/30/1910-Q
5/23/19
3/31/1910-Q
3/25/194
3/19/1910-K,  8-K
1/1/19
12/31/1810-K,  SD
9/30/1810-Q
6/30/1810-Q
3/31/1810-Q
12/31/1710-K,  SD
 List all Filings 
Top
Filing Submission 0000819689-19-000099   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 8, 6:31:51.2am ET